Skeletal muscle sodium and potassium changes after successful surgery in acromegaly: relation to body composition, blood glucose, plasma insulin and blood pressure
- PMID: 8317188
- DOI: 10.1530/acta.0.1280418
Skeletal muscle sodium and potassium changes after successful surgery in acromegaly: relation to body composition, blood glucose, plasma insulin and blood pressure
Abstract
The aim of this study was to investigate the skeletal muscle sodium/potassium (Na/K) ratio in acromegaly before and 1 year after trans-sphenoidal removal of a growth hormone (GH)-secreting pituitary adenoma. Muscle biopsies were taken and skeletal muscle electrolytes, body composition, glucose, insulin and blood pressure were studied. Fasting blood glucose and plasma insulin levels, but not blood pressure, were higher in acromegalic patients (N = 9) than in controls (N = 6). The skeletal muscle potassium content was higher (p < 0.01) but the sodium content and the Na/K ratio were lower (p < 0.05 and p < 0.001, respectively) in untreated patients with acromegaly as compared to weight-matched healthy controls. Elevated GH, glucose and insulin levels normalized after surgery. Blood pressure remained unchanged. The total body potassium content, the lean body mass and the total body water content decreased and the body fat content increased while the body weight was unchanged. The skeletal muscle potassium content decreased from [medium (range)] 9.8 (9.2-11.5) to 7.7 (5.7-9.5) mmol/100 g wet wt (p < 0.001). The skeletal muscle sodium content increased from 2.8 (2.5-3.9) to 5.1 (4.3-6.7) mmol/100 g wet wt (p < 0.001) and the Na/K ratio increased from 0.28 (0.26-0.38) to 0.56 (0.51-1.18) (p < 0.001) after surgery, which is a higher level than the controls with a Na/K ratio of 0.47 (0.39-0.84) (p < 0.01). These changes seem to be mediated by a decreased GH effect on the Na/K pump after successful trans-sphenoidal surgery in acromegaly.
Similar articles
-
Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?Clin Endocrinol (Oxf). 2005 Apr;62(4):410-7. doi: 10.1111/j.1365-2265.2005.02233.x. Clin Endocrinol (Oxf). 2005. PMID: 15807870
-
[Lowered ghrelin levels in acromegaly—normalization after treatment].Endokrynol Pol. 2005 Nov-Dec;56(6):862-70. Endokrynol Pol. 2005. PMID: 16821203 Clinical Trial. Polish.
-
Elevated fibrinogen levels decrease following treatment of acromegaly.Clin Endocrinol (Oxf). 1997 Jan;46(1):69-74. doi: 10.1046/j.1365-2265.1997.d01-1743.x. Clin Endocrinol (Oxf). 1997. PMID: 9059560
-
Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.J Neurosurg. 2013 Dec;119(6):1467-77. doi: 10.3171/2013.8.JNS13224. Epub 2013 Sep 27. J Neurosurg. 2013. PMID: 24074496 Review.
-
Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.Neuroendocrinology. 2006;83(3-4):249-57. doi: 10.1159/000095535. Epub 2006 Oct 13. Neuroendocrinology. 2006. PMID: 17047390 Review.
Cited by
-
Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature.Endocrine. 2019 Feb;63(2):348-360. doi: 10.1007/s12020-018-1797-8. Epub 2018 Nov 5. Endocrine. 2019. PMID: 30397873 Review.
-
Skeletal muscle mass in acromegaly assessed by magnetic resonance imaging and dual-photon x-ray absorptiometry.J Clin Endocrinol Metab. 2009 Aug;94(8):2880-6. doi: 10.1210/jc.2009-0026. Epub 2009 Jun 2. J Clin Endocrinol Metab. 2009. PMID: 19491226 Free PMC article.
-
Morphological and histopathological changes in orofacial structures of experimentally developed acromegaly-like rats: an overview.Int J Endocrinol. 2012;2012:254367. doi: 10.1155/2012/254367. Epub 2012 Feb 28. Int J Endocrinol. 2012. PMID: 22518118 Free PMC article.
-
Influence of Disease Activity and Body Composition Parameters on Cross-Sectional Area of the Median Nerve in Acromegalic Patients.Physiol Res. 2021 Dec 30;70(6):921-929. doi: 10.33549/physiolres.934681. Epub 2021 Oct 30. Physiol Res. 2021. PMID: 34717059 Free PMC article.
-
Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly.J Clin Endocrinol Metab. 2008 Jun;93(6):2334-43. doi: 10.1210/jc.2007-2780. Epub 2008 Mar 18. J Clin Endocrinol Metab. 2008. PMID: 18349062 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous